Prenetics

Prenetics Global Limited (NASDAQ: PRE) is a health sciences company headquartered in the Cayman Islands, with offices in the US and Hong Kong. Founded in 2014, Prenetics works to advance consumer and clinical health through genetic testing and early disease detection. Its consumer brand, IM8, leads wellness initiatives, while Insighta focuses on early cancer detection technologies. Prenetics also offers DNA testing through CircleDNA, which uses advanced sequencing to provide insights into health, wellness, and genetic risks.

Prenetics is also working to connect genetics with blockchain technology. It has partnered with Humanity Protocol, a company that verifies identities using decentralized systems. Through this partnership, CircleDNA is now part of Humanity Protocol's platform, which helps issue blockchain-based Proof of Personhood credentials. This effort highlights Prenetics' commitment to secure identity verification by linking genetic data with blockchain.

Prenetics also takes a strategic approach to digital assets such as Bitcoin. Its investments in this area support its broader goal of using blockchain technology in its operations. By combining health sciences with digital innovation, Prenetics aims to strengthen its market position and offer advanced solutions in health science.